Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material

A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Pl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 1980-05, Vol.18 (3), p.431-437
Hauptverfasser: Barlow, G.H., Marder, V.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 437
container_issue 3
container_start_page 431
container_title Thrombosis research
container_volume 18
creator Barlow, G.H.
Marder, V.J.
description A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.
doi_str_mv 10.1016/0049-3848(80)90338-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75260813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0049384880903382</els_id><sourcerecordid>75260813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</originalsourceid><addsrcrecordid>eNp9kE1v1DAQhi0EKkvhH4DkE4JD2rGdxPYFqar4qFSJHuBsOc4EDElcPHGl_fd42VWPnGak92NGD2OvBVwIEP0lQGsbZVrzzsB7C0qZRj5hO2G0bWSr5VO2e7Q8Zy-IfgEILWx3xs56aw20Ysfy3exp8bzk9DuunpDP-IAz8QU9lYwjH_Y8_MxpST9wjYF7Ir_nftow87hOhWJaiaeJb5GoIA9l3mqOp1w7a2Pec0olB-SLr5no55fs2eRnwlenec6-f_r47fpLc_v188311W0TVKe3prNa6uARoPOdHQdpNEwQEAbVDaP1Qx_CBIhhGqVU42Hz3lscdT-AMlads7fH3vuc_hSkzS2RAs6zXzEVcrqTPRihqrE9GkNORBknd5_jUj93AtwBtTtwdAeOzoD7h9rJGntz6i_DguNj6MS26h-OesWJDxGzoxBxDTjGjGFzY4r_P_AXjMWRfg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75260813</pqid></control><display><type>article</type><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Barlow, G.H. ; Marder, V.J.</creator><creatorcontrib>Barlow, G.H. ; Marder, V.J.</creatorcontrib><description>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/0049-3848(80)90338-2</identifier><identifier>PMID: 6998041</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Chromogenic assay ; Chromogenic Compounds ; Culture Techniques ; Endopeptidases - blood ; Fibrinolysis ; Humans ; Infusions, Parenteral ; Molecular Weight ; plasminogen activator ; therapeutic thrombolysis ; Time Factors ; urokinase ; Urokinase-Type Plasminogen Activator - blood ; Urokinase-Type Plasminogen Activator - urine</subject><ispartof>Thrombosis research, 1980-05, Vol.18 (3), p.431-437</ispartof><rights>1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</citedby><cites>FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0049-3848(80)90338-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6998041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barlow, G.H.</creatorcontrib><creatorcontrib>Marder, V.J.</creatorcontrib><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</description><subject>Chromogenic assay</subject><subject>Chromogenic Compounds</subject><subject>Culture Techniques</subject><subject>Endopeptidases - blood</subject><subject>Fibrinolysis</subject><subject>Humans</subject><subject>Infusions, Parenteral</subject><subject>Molecular Weight</subject><subject>plasminogen activator</subject><subject>therapeutic thrombolysis</subject><subject>Time Factors</subject><subject>urokinase</subject><subject>Urokinase-Type Plasminogen Activator - blood</subject><subject>Urokinase-Type Plasminogen Activator - urine</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v1DAQhi0EKkvhH4DkE4JD2rGdxPYFqar4qFSJHuBsOc4EDElcPHGl_fd42VWPnGak92NGD2OvBVwIEP0lQGsbZVrzzsB7C0qZRj5hO2G0bWSr5VO2e7Q8Zy-IfgEILWx3xs56aw20Ysfy3exp8bzk9DuunpDP-IAz8QU9lYwjH_Y8_MxpST9wjYF7Ir_nftow87hOhWJaiaeJb5GoIA9l3mqOp1w7a2Pec0olB-SLr5no55fs2eRnwlenec6-f_r47fpLc_v188311W0TVKe3prNa6uARoPOdHQdpNEwQEAbVDaP1Qx_CBIhhGqVU42Hz3lscdT-AMlads7fH3vuc_hSkzS2RAs6zXzEVcrqTPRihqrE9GkNORBknd5_jUj93AtwBtTtwdAeOzoD7h9rJGntz6i_DguNj6MS26h-OesWJDxGzoxBxDTjGjGFzY4r_P_AXjMWRfg</recordid><startdate>19800501</startdate><enddate>19800501</enddate><creator>Barlow, G.H.</creator><creator>Marder, V.J.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19800501</creationdate><title>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</title><author>Barlow, G.H. ; Marder, V.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-59727cae005a59db2870f0ce0b35bd9ab6ccf0eecfd223d0eecaaa9ed76b03893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Chromogenic assay</topic><topic>Chromogenic Compounds</topic><topic>Culture Techniques</topic><topic>Endopeptidases - blood</topic><topic>Fibrinolysis</topic><topic>Humans</topic><topic>Infusions, Parenteral</topic><topic>Molecular Weight</topic><topic>plasminogen activator</topic><topic>therapeutic thrombolysis</topic><topic>Time Factors</topic><topic>urokinase</topic><topic>Urokinase-Type Plasminogen Activator - blood</topic><topic>Urokinase-Type Plasminogen Activator - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barlow, G.H.</creatorcontrib><creatorcontrib>Marder, V.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barlow, G.H.</au><au>Marder, V.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>1980-05-01</date><risdate>1980</risdate><volume>18</volume><issue>3</issue><spage>431</spage><epage>437</epage><pages>431-437</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>A standard curve of urokinase activity versus optical density was established for high molecular weight and low molecular weight urokinase molecules using the chromogenic substrate L-pyroglutamyl-glycyl-L-arginine-p-nitroanalide (KABI S-2444) and a World Health Organization urokinase preparation. Plasma urokinase levels were determined on samples collected during and after infusions of tissue culture or urinary source urokinase. The urinary source material achieved a significantly higher plasma blood level at the first sampling interval (2 hours) and disappeared more rapidly after termination of the infusion, than did tissue culture material. There was no correlation of the plasma chromogenic assay level with the plasma fibrinogen or plasminogen concentration nor with any other parameter associated with the “lytic state”. Both urokinase materials achieved plasma levels in excess of that required to produce a fibrinogenolytic state, and it is likely that a lower dose could be used to achieve the “lytic state”.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>6998041</pmid><doi>10.1016/0049-3848(80)90338-2</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 1980-05, Vol.18 (3), p.431-437
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_75260813
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Chromogenic assay
Chromogenic Compounds
Culture Techniques
Endopeptidases - blood
Fibrinolysis
Humans
Infusions, Parenteral
Molecular Weight
plasminogen activator
therapeutic thrombolysis
Time Factors
urokinase
Urokinase-Type Plasminogen Activator - blood
Urokinase-Type Plasminogen Activator - urine
title Plasma urokinase levels measured by chromogenic assay after infusions of tissue culture or urinary source material
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T06%3A23%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20urokinase%20levels%20measured%20by%20chromogenic%20assay%20after%20infusions%20of%20tissue%20culture%20or%20urinary%20source%20material&rft.jtitle=Thrombosis%20research&rft.au=Barlow,%20G.H.&rft.date=1980-05-01&rft.volume=18&rft.issue=3&rft.spage=431&rft.epage=437&rft.pages=431-437&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/0049-3848(80)90338-2&rft_dat=%3Cproquest_cross%3E75260813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75260813&rft_id=info:pmid/6998041&rft_els_id=0049384880903382&rfr_iscdi=true